News
New weight loss drugs appeal to half of U.S. adults
Surveyed interest fell markedly when respondents answered further questions that hinged on certain limitations of the newer weight loss...
News
‘Triple G’ agonist hits new weight loss heights
This level of weight loss is “unprecedented” for a medication administered for 48 weeks.
News
Growth hormone links with worse T2D control in adolescents
Researchers hope to “leverage these data to find predictive markers” that could identify adolescents with type 2 diabetes “at risk for...
News
Time-restricted eating gains for weight and glycemic control
While no evidence clearly shows that 8 hours is the best eating-window duration, “we think 8 hours is a good sweet-spot for motivated people.”
News
Benefits of bariatric surgery persist for 12 years
The results reinforce the potential role of surgery “as an option to improve diabetes-related outcomes, including people with a BMI of less than...
News
Semaglutide use surges in U.S. adults with type 2 diabetes
“The market share of GLP-1 agonists is likely to expand in patients with type 2 diabetes,” especially those who also have obesity.
News
Tirzepatide powers weight loss in two more pivotal trials
These weight-loss levels, 26.0% and 26.6%, were “the highest level of weight loss observed in the SURMOUNT program to date.”
News
SGLT2 inhibitors linked with fewer gout flares in diabetes
“SGLT2 inhibitors may offer distinct benefits,” making the drug class “a particularly attractive addition to current urate-lowering therapies.”
News
Affording the cost of new obesity drugs? We can’t afford not to
“Patient happiness and self-esteem are hard to measure and capture as cost impacts. We need to also add carbon dioxide effects and transportation...
News
FDA approves cognitive-behavioral app for adults with type 2 diabetes
The app will be available to patients exclusively by prescription, with a planned 90-day use duration.
News
Education before Ramadan key to safe fasting with diabetes
“With correct advice and support” from knowledgeable health care professionals “most people with type 2 diabetes can fast safely during Ramadan...
News
Triple-agonist retatrutide hits new weight loss highs
“I have never seen weight loss at this level” after nearly 1 year of treatment.
News
Children with type 2 diabetes face dire complications as young adults
Arterial stiffness and worsened cardiac function often appear in these children within 2-5 years of diagnosis and seem driven in part by the...
News
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
Taken together, results from SURMOUNT-1 and SURMOUNT-2 appear to make a good case for a weight-loss indication that will not depend on whether a...